ICON PLC (ICLR)
| Market Cap | 26.05B |
| Revenue (ttm) | 8.23B |
| Net Income (ttm) | 683.12M |
| Shares Out | 82.68M |
| EPS (ttm) | 8.23 |
| PE Ratio | 37.88 |
| Forward PE | 20.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 396,034 |
| Open | 312.26 |
| Previous Close | 311.75 |
| Day's Range | 311.36 - 315.73 |
| 52-Week Range | 189.58 - 344.77 |
| Beta | 1.16 |
| Analysts | Strong Buy |
| Price Target | 321.64 (+2.1%) |
| Earnings Date | Apr 24, 2024 |
About ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient a... [Read more]
Financial Performance
In 2023, ICON PLC's revenue was $8.12 billion, an increase of 4.89% compared to the previous year's $7.74 billion. Earnings were $612.34 million, an increase of 21.18%.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for ICLR stock is "Strong Buy." The 12-month stock price forecast is $321.64, which is an increase of 2.10% from the latest price.
News
ICON Announces Pricing of USD 2 Billion Notes
DUBLIN--(BUSINESS WIRE)--ICON Announces Pricing of USD 2 Billion Notes.
ICON Reports First Quarter 2024 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2024 Results.
Eight stock picks in AI, obesity drugs, e-commerce and other growth areas beyond the S&P 500
It is understandable for U.S. investors to be focused on the largest technology companies that have driven such strong performance for the S&P 500 over the past decade. But learning about strategies t...
ICON Announces CFO Transition
DUBLIN--(BUSINESS WIRE)--ICON Announces CFO Transition.
ICON plc Schedules First Quarter 2024 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules First Quarter 2024 Earnings Conference Call.
ICON plc to Present at Upcoming Investor Conferences
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at Upcoming Investor Conferences.
ICON Reports Fourth Quarter and Full Year 2023 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2023 Results.
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call.
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference.
ICON Reports Third Quarter 2023 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports Third Quarter 2023 Results.
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Third Quarter 2023 Earnings Conference Call.
Final Trades: Blackstone, Uber & more
The "Halftime Report" traders give their top picks to watch for the second half.
ICON plc to Present at the Baird Global Healthcare Conference
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the Baird Global Healthcare Conference.
Icon PLC: A High-Performing Stock with Strong Growth and Profitability
Icon PLC ( ICLR , Financial), a leading player in the Medical Diagnostics & Research industry, has been making waves in the stock market. As of July 28, 2023, the company's stock price stands at $250....
ICON Reports Second Quarter 2023 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports Second Quarter 2023 Results.
ICON plc Schedules Second Quarter 2023 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Second Quarter 2023 Earnings Conference Call.
ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform
DUBLIN--(BUSINESS WIRE)-- #DCTs--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced the latest release of its Digital Platform. The pl...
ICON plc Set to Join Russell 3000® Index
DUBLIN--(BUSINESS WIRE)--ICON plc set to join Russell 3000® Index.
ICON plc to Attend Upcoming Investor Conferences
DUBLIN--(BUSINESS WIRE)--ICON plc to Attend Upcoming Investor Conferences.
ICON Reports First Quarter 2023 Results
DUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2023 Results.
ICON plc Schedules First Quarter 2023 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules First Quarter 2023 Earnings Conference Call
LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology
BALLERUP, Denmark & DUBLIN--(BUSINESS WIRE)-- #partnership--LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO...
ICON Reports Fourth Quarter and Full Year 2022 Results
DUBLIN, Ireland--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2022 Results
ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call
DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced that it will release its financial results for the four...